JP Patent
JP7595413B2 — 15-pgdh阻害剤とコルチコステロイドおよび/またはtnf阻害剤との組み合わせならびにその使用
Assigned to ケース ウエスタン リザーブ ユニバーシティ · Expires 2024-12-06 · 1y expired
What this patent protects
Patent listed against Crenessity.
Drugs covered by this patent
- Crenessity (CRINECERFONT) · Neurocrine
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.